Liver, but not adipose tissue PEDF gene expression is associated with insulin resistance. 2013

J M Moreno-Navarrete, and V Touskova, and M Sabater, and M Mraz, and J Drapalova, and F Ortega, and M Serrano, and V Catalán, and J Gómez-Ambrosi, and M R Ortiz, and G Pardo, and N Pueyo, and W Ricart, and Z Lacinova, and M Haluzik, and G Frühbeck, and J M Fernández-Real
Department of Diabetes, Endocrinology and Nutrition, Institut d'Investigació Biomèdica de Girona, and CIBER Fisiopatologia Obesidad y Nutricion (CB06/03/010), Instituto de Salud Carlos III, Girona, Spain.

OBJECTIVE Recent studies linked circulating pigment epithelium-derived factor (PEDF) to obesity-associated insulin resistance, but the main source of circulating PEDF is unknown. We aimed to investigate liver and adipose tissue PEDF gene expression in association with obesity and insulin resistance. METHODS Three (two cross-sectional and one longitudinal) independent cohorts have been studied, for adipose tissue (n=80 and n=30) and liver gene expression (n=32 and n=14). Effects of high glucose and cytokines on HepG2 cell line were also investigated. PEDF gene expression and circulating PEDF were analyzed using real-time PCR and ELISA, respectively. RESULTS In a first cohort of subjects, PEDF relative gene expression was higher in subcutaneous (SC) than in omental (OM) adipose tissue (P<0.0001) being also higher in mature adipocytes compared with stromo-vascular cells (P<0.0001). However, OM PEDF relative gene expression was decreased in morbidly obese subjects (P=0.01). Both OM PEDF and OM PEDF receptor (PEDFR) correlated positively with lipogenic and lipolytic genes, and with genes implicated in the lipid vacuole formation. Circulating PEDF levels were not associated with fat PEDF gene expression. In the second cohort, SC PEDF was decreased in subjects with type 2 diabetes and did not change significantly after weight loss. We next explored circulating PEDF in association with markers of liver-related insulin resistance injury (alanine aminotransferase, r=0.59, P=0.001). Interestingly, liver PEDF gene expression increased with obesity and insulin resistance in men, being significantly associated with fasting glucose and glycated hemoglobin in two independent cohorts. In fact, high glucose led to increased PEDF in HepG2 cells, while inflammatory stimuli present in the adipose tissue environment downregulated PEDF. CONCLUSIONS Liver, but not adipose tissue, might be the source of increased circulating PEDF linked to insulin resistance.

UI MeSH Term Description Entries
D007333 Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. Insulin Sensitivity,Resistance, Insulin,Sensitivity, Insulin
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008137 Longitudinal Studies Studies in which variables relating to an individual or group of individuals are assessed over a period of time. Bogalusa Heart Study,California Teachers Study,Framingham Heart Study,Jackson Heart Study,Longitudinal Survey,Tuskegee Syphilis Study,Bogalusa Heart Studies,California Teachers Studies,Framingham Heart Studies,Heart Studies, Bogalusa,Heart Studies, Framingham,Heart Studies, Jackson,Heart Study, Bogalusa,Heart Study, Framingham,Heart Study, Jackson,Jackson Heart Studies,Longitudinal Study,Longitudinal Surveys,Studies, Bogalusa Heart,Studies, California Teachers,Studies, Jackson Heart,Studies, Longitudinal,Study, Bogalusa Heart,Study, California Teachers,Study, Longitudinal,Survey, Longitudinal,Surveys, Longitudinal,Syphilis Studies, Tuskegee,Syphilis Study, Tuskegee,Teachers Studies, California,Teachers Study, California,Tuskegee Syphilis Studies
D008297 Male Males
D009414 Nerve Growth Factors Factors which enhance the growth potentialities of sensory and sympathetic nerve cells. Neurite Outgrowth Factor,Neurite Outgrowth Factors,Neuronal Growth-Associated Protein,Neuronotrophic Factor,Neurotrophic Factor,Neurotrophic Factors,Neurotrophin,Neurotrophins,Growth-Associated Proteins, Neuronal,Neuronal Growth-Associated Proteins,Neuronotrophic Factors,Neurotrophic Protein,Neurotrophic Proteins,Proteins, Neuronal Growth-Associated,Factor, Neurite Outgrowth,Factor, Neuronotrophic,Factor, Neurotrophic,Factors, Nerve Growth,Factors, Neurite Outgrowth,Factors, Neuronotrophic,Factors, Neurotrophic,Growth Associated Proteins, Neuronal,Growth-Associated Protein, Neuronal,Neuronal Growth Associated Protein,Neuronal Growth Associated Proteins,Outgrowth Factor, Neurite,Outgrowth Factors, Neurite,Protein, Neuronal Growth-Associated
D009767 Obesity, Morbid The condition of weighing two, three, or more times the ideal weight, so called because it is associated with many serious and life-threatening disorders. In the BODY MASS INDEX, morbid obesity is defined as having a BMI greater than 40.0 kg/m2. Morbid Obesity,Obesity, Severe,Morbid Obesities,Obesities, Morbid,Obesities, Severe,Severe Obesities,Severe Obesity
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked

Related Publications

J M Moreno-Navarrete, and V Touskova, and M Sabater, and M Mraz, and J Drapalova, and F Ortega, and M Serrano, and V Catalán, and J Gómez-Ambrosi, and M R Ortiz, and G Pardo, and N Pueyo, and W Ricart, and Z Lacinova, and M Haluzik, and G Frühbeck, and J M Fernández-Real
January 2016, Disease markers,
J M Moreno-Navarrete, and V Touskova, and M Sabater, and M Mraz, and J Drapalova, and F Ortega, and M Serrano, and V Catalán, and J Gómez-Ambrosi, and M R Ortiz, and G Pardo, and N Pueyo, and W Ricart, and Z Lacinova, and M Haluzik, and G Frühbeck, and J M Fernández-Real
December 2011, Journal of inherited metabolic disease,
J M Moreno-Navarrete, and V Touskova, and M Sabater, and M Mraz, and J Drapalova, and F Ortega, and M Serrano, and V Catalán, and J Gómez-Ambrosi, and M R Ortiz, and G Pardo, and N Pueyo, and W Ricart, and Z Lacinova, and M Haluzik, and G Frühbeck, and J M Fernández-Real
March 2006, International journal of obesity (2005),
J M Moreno-Navarrete, and V Touskova, and M Sabater, and M Mraz, and J Drapalova, and F Ortega, and M Serrano, and V Catalán, and J Gómez-Ambrosi, and M R Ortiz, and G Pardo, and N Pueyo, and W Ricart, and Z Lacinova, and M Haluzik, and G Frühbeck, and J M Fernández-Real
February 2019, Diabetes/metabolism research and reviews,
J M Moreno-Navarrete, and V Touskova, and M Sabater, and M Mraz, and J Drapalova, and F Ortega, and M Serrano, and V Catalán, and J Gómez-Ambrosi, and M R Ortiz, and G Pardo, and N Pueyo, and W Ricart, and Z Lacinova, and M Haluzik, and G Frühbeck, and J M Fernández-Real
October 2023, Diabetes/metabolism research and reviews,
J M Moreno-Navarrete, and V Touskova, and M Sabater, and M Mraz, and J Drapalova, and F Ortega, and M Serrano, and V Catalán, and J Gómez-Ambrosi, and M R Ortiz, and G Pardo, and N Pueyo, and W Ricart, and Z Lacinova, and M Haluzik, and G Frühbeck, and J M Fernández-Real
February 2024, Biological trace element research,
J M Moreno-Navarrete, and V Touskova, and M Sabater, and M Mraz, and J Drapalova, and F Ortega, and M Serrano, and V Catalán, and J Gómez-Ambrosi, and M R Ortiz, and G Pardo, and N Pueyo, and W Ricart, and Z Lacinova, and M Haluzik, and G Frühbeck, and J M Fernández-Real
June 2019, Obesity (Silver Spring, Md.),
J M Moreno-Navarrete, and V Touskova, and M Sabater, and M Mraz, and J Drapalova, and F Ortega, and M Serrano, and V Catalán, and J Gómez-Ambrosi, and M R Ortiz, and G Pardo, and N Pueyo, and W Ricart, and Z Lacinova, and M Haluzik, and G Frühbeck, and J M Fernández-Real
January 2013, PloS one,
J M Moreno-Navarrete, and V Touskova, and M Sabater, and M Mraz, and J Drapalova, and F Ortega, and M Serrano, and V Catalán, and J Gómez-Ambrosi, and M R Ortiz, and G Pardo, and N Pueyo, and W Ricart, and Z Lacinova, and M Haluzik, and G Frühbeck, and J M Fernández-Real
January 2004, Annales de biologie clinique,
J M Moreno-Navarrete, and V Touskova, and M Sabater, and M Mraz, and J Drapalova, and F Ortega, and M Serrano, and V Catalán, and J Gómez-Ambrosi, and M R Ortiz, and G Pardo, and N Pueyo, and W Ricart, and Z Lacinova, and M Haluzik, and G Frühbeck, and J M Fernández-Real
July 2022, Obesity (Silver Spring, Md.),
Copied contents to your clipboard!